Trial intelligence / Profile preview

Interferon-gamma Triple Therapy for Hepatitis C Non-responders

NCT00538811Phase 3Completed

Sponsor
Aga Khan University
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of interferon gamma-1b in hepatitis C (HCV), sponsored by Aga Khan University. Status: completed.

02

Drugs

interferon gamma-1b
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00538811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00538811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call